Patent Application
20210177664
The invention pertains generally to the field of wound or insertion site dressings, and more particularly to a dressing with a perforable absorbent portion, avoiding constant removal of an adhesive from an applied skin surface.
One of the most pervasive—yet largely unacknowledged—medical conditions seen within any care setting and amongst any age group is a condition known as Medical-Adhesive Related Skin Injury, or MARSI. While a convenient acronym, it is not so convenient for those affected by the condition. For those susceptible, MARSI is manifested as an erythema, trauma, or other reaction, including formation of vesicles, skin erosion, epidermal tears, or bulla, just shortly after removal of an adhesive from a wound or insertion site-adjacent skin surface. In short and in simple terms, MARSI is caused by constant exposure and removal of an adhesive from a skin surface of a dermatologically susceptible patient. As earlier stated, it is blind to patient age and standard of patient care or setting, and for those roughly 20% of adhesive bandage-clad patients inflicted with MARSI, it deeply impacts their health, safety, and above all else, quality of life. Suffice it to say, adding yet another medical complication onto the bevy of conditions that the patient is already being treated for does not help in containing spiraling health care costs.
More specifically, there are a number of different types of MARSI, each exhibiting their own specific symptom or indication. Whether MARSI dermatitis, maceration, or folliculitis, they all share a common symptom: Pain and irritation to a patient, whom in all likelihood, is already managing the pain and discomfort from the condition the initial treatment was sought after. MARSI dermatitis is characterized by skin redness with clearly defined borders, and in certain cases, can result in an allergic reaction in which vesicles appear for weeks on-end after removal of the adhesive. MARSI maceration is far easier to detect and diagnose due to the appearance of greyness or whiteness of the skin after adhesive removal. Additionally, wrinkling of the adhesive-exposed surface of the skin occurs, further risking the patient for tearing, abrasion, or rupturing the skin, leading to infections. Finally, MARSI folliculitis is characterized by pustules or papules formed at the hair follicles residing on the adhesive-exposed surface of the skin.
The etiology underlying MARSI is understood as being due to a stronger adhesion between skin-adhesive layer compared to skin-skin and the subsequent mechanical pulling of the skin-adhesive layer from underlying skin layers resulting in the removal of the epidermis from the dermis. The exposed dermis alters the patients skin barrier function, resulting in rendering the patient prone to the infections and immunological responses underlying the symptoms and indications described above. This removal of epidermis and exposure of dermis is further exacerbated during constant mechanical pulling of the adhesive layer or skin-adhesive layer as a result of constant re-bandaging or re-dressing required with patients experiencing excess exudate or discharge. Another risk factor not mentioned is the risk of dislodging a tube insertion as a result of the constant mechanical pulling.
As with other pathologies, prevention is the best treatment. However, in the case of MARSI, complete prevention is all but futile, with practitioners and care givers resigned to mitigation and crossed fingers. Mitigation comes in the form of using foam and silicone tape, such as 3M's Medipore tape, which are softer and gentler on the skin. Additionally, removing the adhesive slowly in the direction of hair growth and the tape parallel with the skin and pushing the skin away from the tape with the other hand is yet another mitigating factor. However, neither of these mitigating factors or products in the market address the broader underlying issue, which is the constant removal of an adhesive due to re-bandaging/dressing to address excess exudate/discharge.
Despite the risk posed by repeated pulling of an adhesive, there is currently a void in the market and prior art for outright prevention of this risk. Thus, there is a need for a bandage/dressing apparatus and method for preventing the risk of MARSI by minimizing the occurrences of adhesive removal from a wound, tube-insertion site, or adjacent site. It is blatantly evident that mere proper technique of application and removal of adhesives with the current products in the market are inadequate in addressing this growing medical concern—costing the well-being and quality of life for patients and their loved ones alike, not to mention the overall resource and financial burden on the healthcare system.
The invention resides in enabling a healthcare provider or loved one to avoid the constant or repeated removal of an adhesive layer on an applied skin surface, thereby preventing the mechanical pulling of the superficial epidermal layer, exposing the dermis to risk of MARSI. Advantageously, the avoidance of constant pulling of an adhesive layer prevents the risk of tube dislodgement during catheterization and the like.
It is one object of the present disclosure to provide an apparatus for removing a dressing or bandage without removing an adhesive portion comprising: an absorbent portion; an adhesive frame; the absorbent portion coupled to the adhesive frame by a perforated border (perforable absorbent portion bandage—PAP-B); and the perforated border with a loose or hanging tab, whereby a user holds the tab and pulls in any one of a direction of any one of an edge of the perforated border to loosen free the absorbent portion from the adhesive frame, thereby freeing the absorbent portion from an applied skin surface without a need for removing the adhesive frame from the applied skin surface.
It is another object of the present disclosure to provide for an apparatus for dressing a wound comprising: an absorbent central portion; an adhesive frame; and the absorbent central portion perforably coupled to the adhesive frame (PAP-B), wherein the adhesive frame is further adhered to any one of a foundation layer with a central opening therebetween, wherein a bottom surface of the adhesive frame is adhered to a top surface of the foundation and a bottom surface of the foundation is applied to and adhered onto an applied skin surface. Preferably, the foundation would have a square or circle shape with a center aperture/opening to accommodate a PAP-B over a wound, tube-insertion site, or adjacent site.
It is yet another object to dispose a center aperture or opening on the PAP-B, along with a slit opening along any one of an edge of the PAP-B, running through-line into the interior and terminating into the center aperture/opening in order to accommodate a tube insertion. Likewise, the foundation layer may also be disposed with a slit opening along any one of an edge of the foundation, running through-line across any one of the frames or borders of the foundation and terminating into the center aperture/opening of the foundation in order to accommodate a tube insertion.
Finally, it is yet another object to provide for a method for applying and removing a dressing without removing an adhesive portion comprising the steps of: firstly, coupling an absorbent central portion to an adhesive frame by a perforated border; secondly, holding a tab disposed at any point of the perforated border, whereby a user holds the tab; thirdly, pulling the tab in any one of a direction of an edge of the perforated border to loosen free the absorbent portion from the adhesive frame; fourthly, applying at least a second adhesive frame coupled to the absorbent portion onto a previously applied first adhesive frame top surface, thereby not requiring constant removal of the adhesive frame from the applied skin surface; and finally, removing only a last applied absorbent portion and a first applied adhesive frame from the applied skin surface once wound or insertion site dressing is no longer required.
The drawings illustrate the design and utility of embodiments of the present invention, in which similar elements are referred to by common reference numerals. In order to better appreciate the advantages and objects of the embodiments of the present invention, reference should be made to the accompanying drawings that illustrate these embodiments.
However, the drawings depict only some embodiments of the invention, and should not be taken as limiting its scope. With this caveat, embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
In the following description, for purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of the invention. It will be apparent, however, to one skilled in the art that the invention can be practiced without these specific details.
Reference in this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the invention. The appearances of the phrase “in one embodiment” in various places in the specification are not necessarily all referring to the same embodiment, nor are separate or alternative embodiments mutually exclusive of other embodiments. Moreover, various features are described which may be exhibited by some embodiments and not by others. Similarly, various requirements are described which may be requirements for some embodiments but not other embodiments.
The present embodiments disclose apparatus and methods for allowing one to perforably-remove an absorption layer without a constant removal of an adhesive frame.
The claimed invention eliminates the need for constant removal of an adhesive during re-bandaging, and as a result, preventing the risk of MARSI and other dermatological conditions alike, not to mention the risk of tube dislodgement. The claimed invention allows for a user to hold a tab and pull in any one of a direction of any one of an edge of the perforated border to loosen free the absorbent portion from the adhesive frame, thereby freeing the absorbent portion from an applied skin surface without a need for removing the adhesive frame from the applied skin surface for mitigating against a risk of MARSI, tube dislodgement, or any risk associated with constant adhesive tape removal from a skin surface during long-term wound or tube insertion dressing.
Constant removal is especially a concern for patients with embedded percutaneous devices, such as catheters, whereby excess fluid or leakage persists. In such patients, prolonged exposure to a soaked dressing (due to leakage) that rests directly on skin, coupled with frequent dressing changes, result in skin irritation, and in severe cases, open sores and wounds. Severity of damage to the skin gets progressively worse as the duration of leakage exposure persists and the frequency of dressing changes increases.
For these patients, it is a constant trade-off between changing the dressing (and thus causing the patient discomfort and skin irritation) versus leaving the soiled dressing on a patient's skin (which also causes irritation, particularly if the leakage is acidic, as is the case with bile). Changing dressings are also time and labor intensive. Nurses (or other caregivers) have to be meticulously careful when changing dressings with current products on the market because they all involve applications of adhesive directly to the skin, which is time-consuming and laborious to remove.
The proposed apparatus and method allows for skin to be protected from repeated lifting and application of adhesive, as well as protect against any excess fluids that might leak from the site of the catheter. If there is existing skin irritation, wound care can also be applied and sealed within to aid in the healing process. In one embodiment, the apparatus comprises the application of a “foundation” layer of a thin layer of adhesive with a cut-out hole and a slit to go around the drain site. This layer is hypoallergenic, breathable, and waterproof and is intended to adhere to the skin for a long duration and a “dressing” layer or PAP-B that will adhere to the foundational layer for every dressing change. The PAP-B is intended to be changed as often as needed and will be perforated for ease of change. Current wound dressings contain an adhesive over the entire surface of a bottom side applied to the patient's skin. Removal of this excessive adhesive is a general pain point during the dressing change process. The adhesive frame of the PAP-B remaining adhered on top the foundation layer, while the inner absorption portion of the PAP-B is easily perforated for removal, thereby enabling caretakers and practitioners to easily puncture the dressing and remove the soiled dressing. New dressings can be re-applied over the surface of the intact adhesive frame remaining intact on top of the foundation layer, which will not require changing unless there is visible signs of skin irritation. This will preserve the integrity of the skin, reducing irritation while making the process more efficient for nurses and caregivers.
In another preferred embodiment, the adhesive frame of the PAP-B may form a sufficiently stable adhesive contact directly with the patients skin, thereby negating the need for the initial foundation layer. In this “one-layer” embodiment, the PAP-B may have a wider or larger adhesive frame in comparison to the adhesive frame of the PAP-B of the two-layer system. The inner absorption portion may be perforated for removal in similar fashion as with the two-layer system—pulling a tab in any direction along a perforated border.
While the size of the PAP-B 10 is difficult to ascertain from
In a preferred embodiment, latex may often be the most common material of the adhesive frame 14, but plastic, silicate, silicate silicone, polyethylene, or polyurethane may also be used to serve as the material of the adhesive frame 14. The critical feature of the material is that it must be comprised of a moisture-permeable material to protect against exudate strike-through, while still being semi-porous and breathable enough to mitigate the risk of maceration. Moreover, the top surface of the adhesive frame 14 does not comprise an adhesive, with only the bottom surface needing to adhere to a skin or foundation surface. Adhesion may be achieved by any one of an adhesive with a coefficient of adhesion suitable for causing stable contact with a skin surface, while being easily removable from the skin-contact surface. Coefficient of adhesion is a reference to the degree of “stickiness”; the lower the coefficient implying a lower level of “stickiness” between the bottom surface of the adhesive frame with an applied surface (patients skin or top surface of a foundation layer). Examples may include an acrylate, vinyl resin, methacrylate, or epoxy diacrylate-based adhesive. Finally, in a preferred embodiment, the adhesive frame is conformable and water-resistant.
In continuing reference to
After perforated removal of the soiled absorbent portion, the next PAP-B may be adhered to the previously existing adhesive frame 32. The next PAP-B adhesive frame 34 stacked on top of the previously existing adhesive frame 32 (Shown in
As shown in
As shown, the foundation layer 65 is disposed with a slit 67 opening along any point of a perimeter of the foundation layer 65, running laterally through the foundation layer 65, and terminating in the central opening 66 to accommodate the tube/insertion 68. As shown in
The foregoing descriptions of specific embodiments of the invention have been presented for purposes of illustration and description. They are not intended to be exhaustive or to limit the invention to the precise forms disclosed. Modifications and variations are possible in light of the above teaching. The embodiments were chosen and described in order to explain the principles and the application of the invention, thereby enabling others skilled in the art to utilize the invention in its various embodiments and modifications according to the particular purpose contemplated. The scope of the invention is intended to be defined by the claims appended hereto and their equivalents.
